Stock SANDUPHQ6 SANDU PHARMACEUTICALS LIMITED
Add to a list
To use this feature you must be a member
Log inSign up

Financials Sandu Pharmaceuticals Limited

Equities

SANDUPHQ6

INE751D01014

Pharmaceuticals

Market Closed - Bombay S.E.
Other stock markets
 11:00:57 04/07/2024 BST 		5-day change 1st Jan Change
59.76 INR -1.53% Intraday chart for Sandu Pharmaceuticals Limited +2.59% -12.25%
06-05 Sandu Pharmaceuticals Limited Reports Earnings Results for the Full Year Ended March 31, 2024 CI
06-05 Sandu Pharmaceuticals Limited Reports Earnings Results for the Fourth Quarter Ended March 31, 2024 CI

Valuation

Fiscal Period: March 2018 2019 2020 2021 2022 2023
Capitalization 1 202.9 154.4 83.2 253.1 619.8 593.1
Enterprise Value (EV) 1 283 208.2 80.24 136.7 578.1 570.1
P/E ratio 36.3 x 23.2 x 11.6 x 20.7 x 37.6 x 32.4 x
Yield - - - 1.56% 1.07% 1.44%
Capitalization / Revenue 0.41 x 0.31 x 0.17 x 0.43 x 0.95 x 0.91 x
EV / Revenue 0.58 x 0.42 x 0.17 x 0.23 x 0.88 x 0.87 x
EV / EBITDA 11.6 x 9.56 x 6.29 x 6.91 x 21.5 x 24.5 x
EV / FCF 5.99 x 7.67 x 5.8 x 2.36 x -540 x -50.5 x
FCF Yield 16.7% 13% 17.2% 42.4% -0.19% -1.98%
Price to Book 0.72 x 0.54 x 0.28 x 0.76 x 1.7 x 1.29 x
Nbr of stocks (in thousands) 7,081 7,081 7,081 7,921 8,811 11,362
Reference price 2 28.65 21.80 11.75 31.95 70.35 52.20
Announcement Date 02/10/18 03/09/19 07/09/20 06/09/21 07/09/22 06/09/23
1INR in Million2INR
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: March 2018 2019 2020 2021 2022 2023
Net sales 1 490.2 495.4 483.7 587.6 655 653.5
EBITDA 1 24.36 21.77 12.76 19.8 26.94 23.23
EBIT 1 18.64 15.73 9.034 16.02 23.44 19.69
Operating Margin 3.8% 3.18% 1.87% 2.73% 3.58% 3.01%
Earnings before Tax (EBT) 1 7.552 10.18 9.19 16.81 23.16 22.17
Net income 1 5.615 6.691 7.203 10.92 15.89 15.2
Net margin 1.15% 1.35% 1.49% 1.86% 2.43% 2.33%
EPS 2 0.7900 0.9400 1.017 1.540 1.870 1.612
Free Cash Flow 1 47.27 27.14 13.83 57.97 -1.07 -11.3
FCF margin 9.64% 5.48% 2.86% 9.87% -0.16% -1.73%
FCF Conversion (EBITDA) 194% 124.7% 108.33% 292.82% - -
FCF Conversion (Net income) 841.75% 405.68% 191.97% 530.6% - -
Dividend per Share - - - 0.5000 0.7500 0.7500
Announcement Date 02/10/18 03/09/19 07/09/20 06/09/21 07/09/22 06/09/23
1INR in Million2INR
Estimates

Balance Sheet Analysis

Fiscal Period: March 2018 2019 2020 2021 2022 2023
Net Debt 1 80.1 53.8 - - - -
Net Cash position 1 - - 2.97 116 41.7 23
Leverage (Debt/EBITDA) 3.287 x 2.472 x - - - -
Free Cash Flow 1 47.3 27.1 13.8 58 -1.07 -11.3
ROE (net income / shareholders' equity) 2.02% 2.35% 2.48% 3.48% 4.54% 4.02%
ROA (Net income/ Total Assets) 2.56% 2.23% 1.33% 2.27% 3.04% 2.38%
Assets 1 219.2 300 542.5 482 522.1 639
Book Value Per Share 2 39.70 40.70 41.30 42.30 41.40 40.60
Cash Flow per Share 2 1.920 1.050 1.720 5.720 1.070 2.360
Capex 1 6.83 1.09 1.12 1.27 8.41 10.7
Capex / Sales 1.39% 0.22% 0.23% 0.22% 1.28% 1.64%
Announcement Date 02/10/18 03/09/19 07/09/20 06/09/21 07/09/22 06/09/23
1INR in Million2INR
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Sector Alternative Medicine

1st Jan change Capi.
SANDU PHARMACEUTICALS LIMITED Stock Sandu Pharmaceuticals Limited
-12.25% 7.02M
DONG-E-E-JIAO CO.,LTD. Stock Dong-E-E-Jiao Co.,Ltd.
+22.67% 5.41B
SHIJIAZHUANG YILING PHARMACEUTICAL CO., LTD. Stock Shijiazhuang Yiling Pharmaceutical Co., Ltd.
-35.93% 3.52B
TIANJIN PHARMACEUTICAL DA REN TANG GROUP CORPORATION LIMITED Stock Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited
-6.69% 2.96B
TASLY PHARMACEUTICAL GROUP CO., LTD Stock Tasly Pharmaceutical Group Co., Ltd
-27.73% 2.6B
SHANDONG BUCHANG PHARMACEUTICALS CO., LTD. Stock Shandong Buchang Pharmaceuticals Co., Ltd.
-11.46% 2.29B
HENAN LINGRUI PHARMACEUTICAL CO., LTD. Stock Henan Lingrui Pharmaceutical Co., Ltd.
+38.57% 1.89B
ZHEJIANG JOLLY PHARMACEUTICAL CO.,LTD Stock Zhejiang Jolly Pharmaceutical Co.,LTD
+38.46% 1.47B
TIBET CHEEZHENG TIBETAN MEDICINE CO., LTD. Stock Tibet Cheezheng Tibetan Medicine Co., Ltd.
-16.41% 1.43B
PT INDUSTRI JAMU DAN FARMASI SIDO MUNCUL TBK Stock PT Industri Jamu dan Farmasi Sido Muncul Tbk
+42.86% 1.36B
Alternative Medicine
  1. Stock Market
  2. Equities
  3. SANDUPHQ6 Stock
  4. Financials Sandu Pharmaceuticals Limited